Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.

Front Oncol · 2022 · PMC9357911 · PMID 35957892

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0700

boldest claim

The sentences

showed a trendp=0.06so close (0.05 < p ≤ 0.1)

Patients with T3/T4 tumors represented 41% of the patient cohort ( Table 1 ) and showed a trend toward worse OS compared to T1 and T2 tumors (p=0.06) but no differences in PFS ( Supplemental Figures 1E, F ).

also in 53,322 other papers

a strong trendp=0.07so close (0.05 < p ≤ 0.1)

In support of this, we found a strong trend (p=0.07) between combined EGFR-/CD8+ expression and survival outcomes ( Figure 7E ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.